Treatment of lupus nephritis with CD5 PLUS, an immunoconjugate of an anti-CD5 monoclonal antibody and ricin A chain

scientific article published on 01 July 1992

Treatment of lupus nephritis with CD5 PLUS, an immunoconjugate of an anti-CD5 monoclonal antibody and ricin A chain is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.1780350721
P698PubMed publication ID1377918

P2093author name stringP. E. Lipsky
M. C. Wacholtz
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectmonoclonal antibodyQ422248
lupus nephritisQ1621830
P304page(s)837-839
P577publication date1992-07-01
P1433published inArthritis and RheumatismQ23929027
P1476titleTreatment of lupus nephritis with CD5 PLUS, an immunoconjugate of an anti-CD5 monoclonal antibody and ricin A chain
P478volume35

Reverse relations

cites work (P2860)
Q37351865Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.
Q41552141Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)
Q40904250Are immunoconjugates useful for therapy with autoimmune diseases?
Q40388190Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease
Q33566071Deterioration of renal function in a patient with lupus
Q72097885Efficacy of an anti-CD5-ricin a chain immunoconjugate in an improved human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mouse model
Q41722148Immunological treatment of autoimmune diseases.
Q40599033Lupus therapy
Q38722015Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor.
Q40506580Systemic lupus erythematosus--disease management
Q72441600[Monoclonal antibodies and rheumatoid polyarthritis]

Search more.